FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ken Stein

Research Profile

Activities & Behaviors

Concepts & Ideas

Geographic Areas

Procedures

Disorders

Chemicals & Drugs

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
Jo Thompson-Coon; Bijay Vaidya; Rebecca Whear; Abdul-Kareem Abdul-Rahman; Alison Bethel; Christian A Gericke; Ken Stein
Telephone consultations in place of face to face out-patient consultations for patients discharged from hospital following surgery: a systematic review.
Oriana Ciani; Ruth Garside; Toby Pavey; Ken Stein; Jonathan A C Sterne; Marc Buyse; Rod S Taylor
Comparison of treatment effect sizes associated with surrogate and final patient relevant outcomes in randomised controlled trials: meta-epidemiological study.
Lanting Lu; Hilary Pearce; Chris Roome; James Shearer; Iain A Lang; Ken Stein
Cost effectiveness of oromucosal cannabis-based medicine (sativex®) for spasticity in multiple sclerosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ken Stein (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jo Thompson-Coon; Bijay Vaidya; Rebecca Whear; Abdul-Kareem Abdul-Rahman; Alison Bethel; Christian A Gericke; Ken Stein
Telephone consultations in place of face to face out-patient consultations for patients discharged from hospital following surgery: a systematic review.
BMC health services research 2013;13():128.
2013: Oriana Ciani; Ruth Garside; Toby Pavey; Ken Stein; Jonathan A C Sterne; Marc Buyse; Rod S Taylor
Comparison of treatment effect sizes associated with surrogate and final patient relevant outcomes in randomised controlled trials: meta-epidemiological study.
BMJ (Clinical research ed.) 2013;346():f457.
2012: Lanting Lu; Hilary Pearce; Chris Roome; James Shearer; Iain A Lang; Ken Stein
Cost effectiveness of oromucosal cannabis-based medicine (sativex®) for spasticity in multiple sclerosis.
PharmacoEconomics 2012;30(12):1157-71.
2012: Martin Pitt; Ken Stein; David Worthington; Paritosh Agarwal; Gary A Ford; Kennedy R Lees; Thomas Monks; Martin A James
Will delays in treatment jeopardize the population benefit from extending the time window for stroke thrombolysis?
Stroke; a journal of cerebral circulation 2012;43(11):2992-7.
2012: L Crathorne; J Elston; Mary Bond; C Cooper; Rod S Taylor; G Weiner; Ken Stein
A systematic review of the effectiveness and cost-effectiveness of bilateral multichannel cochlear implants in adults with severe-to-profound hearing loss.
Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery 2012;37(5):342-54.
2012: Jo Thompson Coon; Abdul-Kareem Abdul-Rahman; Kate Boddy; Andrew Collinson; Alice Martin; Ken Stein; Rebecca Whear; Stuart Logan
Interventions to reduce acute paediatric hospital admissions: a systematic review.
Archives of disease in childhood 2012;97(4):304-11.
2012: Lanting Lu; Jaime Peters; Chris Roome; Ken Stein
Cost-effectiveness analysis of degarelix for advanced hormone-dependent prostate cancer.
BJU international 2012;109(8):1183-92.
2012: K Wyatt; L Anderson; Rob Anderson; W Henley; D Hughes; L Klinger; R Lachmann; A Mehta; V Nikolaou; Ken Stein; A Vellodi; S Waldek; S Logan
The effectiveness and cost-effectiveness of enzyme and substrate replacement therapies: a longitudinal cohort study of people with lysosomal storage disorders.
Health technology assessment (Winchester, England) 2012;16(39):1-543.
2012: Sue Child; Ruth Garside; Victoria Goodwin; Tracey Jones-Hughes; Kate Boddy; Ken Stein
Factors influencing the implementation of fall-prevention programmes: a systematic review and synthesis of qualitative studies.
Implementation science : IS 2012;7():91.
2012: Gabriel Rogers; Joanna Thompson-Coon; Martin Hoyle; Z Liu; T Moxham; Martin Pitt; Ken Stein
Dasatinib and nilotinib for imatinib-resistant or -intolerant chronic myeloid leukaemia: a systematic review and economic evaluation.
Health technology assessment (Winchester, England) 2012;16(22):1-410.
2011: Julian Elston; Ken Stein
Public health implications of establishing a national programme to screen young athletes in the UK.
British journal of sports medicine 2011;45(7):576-82.
2010: Caroline Main; Martin Pitt; T Moxham; Ken Stein
The clinical effectiveness and cost-effectiveness of rituximab for the first-line treatment of chronic lymphocytic leukaemia: an evidence review of the submission from Roche.
Health technology assessment (Winchester, England) 2010;14(Suppl. 2):27-32.
2010: Caroline Main; T Moxham; J C Wyatt; J Kay; Rob Anderson; Ken Stein
Computerised decision support systems in order communication for diagnostic, screening or monitoring test ordering: systematic reviews of the effects and cost-effectiveness of systems.
Health technology assessment (Winchester, England) 2010;14(48):1-227.
2010: Julian Elston; Will Honan; Roy Powell; Joe Gormley; Ken Stein
Do metronomes improve the quality of life in people with Parkinson's disease? A pragmatic, single-blind, randomized cross-over trial.
Clinical rehabilitation 2010;24(6):523-32.
2010: Mary Bond; J Elston; Stuart Mealing; Rob Anderson; G Weiner; Rod S Taylor; Ken Stein
Systematic reviews of the effectiveness and cost-effectiveness of multi-channel unilateral cochlear implants for adults.
Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery 2010;35(2):87-96.
2010: Joanna Thompson-Coon; Martin Hoyle; Colin Green; Z Liu; K Welch; T Moxham; Ken Stein
Bevacizumab, sorafenib tosylate, sunitinib and temsirolimus for renal cell carcinoma: a systematic review and economic evaluation.
Health technology assessment (Winchester, England) 2010;14(2):1-184, iii-iv.
2010: Martin Hoyle; Colin Green; Joanna Thompson-Coon; Zulian Liu; Karen Welch; Tiffany Moxham; Ken Stein
Cost-effectiveness of sorafenib for second-line treatment of advanced renal cell carcinoma.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2010;13(1):55-60.
2010: Martin Hoyle; Colin Green; Joanna Thompson-Coon; Zulian Liu; Karen Welch; Tiffany Moxham; Ken Stein
Cost-effectiveness of temsirolimus for first line treatment of advanced renal cell carcinoma.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2010;13(1):61-8.
2009: Mary Bond; Stuart Mealing; Rob Anderson; John Dean; Ken Stein; Rod S Taylor
Is combined resynchronisation and implantable defibrillator therapy a cost-effective option for left ventricular dysfunction?
International journal of cardiology 2009;137(3):206-15.
2009: Martin Pitt; Will Stahl-Timmins; Rob Anderson; Ken Stein
Using information graphics in health technology assessment: toward a structured approach.
International journal of technology assessment in health care 2009;25(4):555-63.
2009: Mary Bond; Stuart Mealing; Rob Anderson; J Elston; G Weiner; R S Taylor; M Hoyle; Z Liu; A Price; Ken Stein
The effectiveness and cost-effectiveness of cochlear implants for severe to profound deafness in children and adults: a systematic review and economic model.
Health technology assessment (Winchester, England) 2009;13(44):1-330.
2009: Joanna Thompson-Coon; Z Liu; M Hoyle; Gabriel Rogers; Colin Green; T Moxham; K Welch; Ken Stein
Sunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma: a systematic review and indirect comparison of clinical effectiveness.
British journal of cancer 2009;101(2):238-43.
2009: Mary Bond; J Elston; S Mealing; R Anderson; G Weiner; Rod S Taylor; Z Liu; Ken Stein
Effectiveness of multi-channel unilateral cochlear implants for profoundly deaf children: a systematic review.
Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery 2009;34(3):199-211.
2009: Ken Stein; Matthew Dyer; Ruairidh Milne; Alison Round; Julie Ratcliffe; John Brazier
The precision of health state valuation by members of the general public using the standard gamble.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2009;18(4):509-18.
2009: Caroline Main; Z Liu; K Welch; G Weiner; S Q Jones; Ken Stein
Surgical procedures and non-surgical devices for the management of non-apnoeic snoring: a systematic review of clinical effects and associated treatment costs.
Health technology assessment (Winchester, England) 2009;13(3):iii, xi-xiv, 1-208.
2008: Ruth Garside; Nicky Britten; Ken Stein
The experience of heavy menstrual bleeding: a systematic review and meta-ethnography of qualitative studies.
Journal of advanced nursing 2008;63(6):550-62.
2008: Caroline Main; Jonathan Shepherd; Rob Anderson; Gabriel Rogers; Joanna Thompson-Coon; Z Liu; Debbie Hartwell; Emma Loveman; Colin Green; Martin Pitt; Ken Stein; P Harris; G K Frampton; M Smith; Andrea Takeda; A Price; K Welch; Margaret Somerville
Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years.
Health technology assessment (Winchester, England) 2008;12(20):1-174, iii-iv.
2008: Jonathan Shepherd; Gabriel Rogers; R Anderson; Caroline Main; Joanna Thompson-Coon; Debbie Hartwell; Z Liu; Emma Loveman; Colin Green; M Pitt; Ken Stein; P Harris; Geoff K Frampton; M Smith; Andrea Takeda; A Price; K Welch; M Somerville
Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.
Health technology assessment (Winchester, England) 2008;12(19):iii-iv, 1-360.
2008: Joanna Thompson-Coon; Gabriel Rogers; Paul Hewson; Dave Wright; Rob Anderson; S Jackson; S Ryder; Matthew Cramp; Ken Stein
Surveillance of cirrhosis for hepatocellular carcinoma: a cost-utility analysis.
British journal of cancer 2008;98(7):1166-75.
2008: Sandy Oliver; Rebecca W Rees; Lorna Clarke-Jones; Ruairidh Milne; Ann Oakley; John Gabbay; Ken Stein; Phyll Buchanan; Gill Gyte
A multidimensional conceptual framework for analysing public involvement in health services research.
Health expectations : an international journal of public participation in health care and health policy 2008;11(1):72-84.
2008: M Somerville; Ruth Garside; M Pitt; Ken Stein
Surveillance of Barrett's oesophagus: is it worthwhile?
European journal of cancer (Oxford, England : 1990) 2008;44(4):588-99.
2008: Michael G Hart; Robert Grant; Ruth Garside; Gabriel Rogers; Margaret Somerville; Ken Stein
Temozolomide for high grade glioma.
Cochrane database of systematic reviews (Online) 2008;(4):CD007415.
2008: Michael G Hart; Robert Grant; Ruth Garside; Gabriel Rogers; Margaret Somerville; Ken Stein
Chemotherapeutic wafers for High Grade Glioma.
Cochrane database of systematic reviews (Online) 2008;(3):CD007294.
2008: Gabriel Rogers; Ruth Garside; Stuart Mealing; Martin Pitt; Rob Anderson; Matthew Dyer; Ken Stein; Margaret Somerville
Carmustine implants for the treatment of newly diagnosed high-grade gliomas: a cost-utility analysis.
PharmacoEconomics 2008;26(1):33-44.
2007: M Fox; Stuart Mealing; Rob Anderson; J Dean; Ken Stein; A Price; Rod S Taylor
The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
Health technology assessment (Winchester, England) 2007;11(47):iii-iv, ix-248.
2007: Ruth Garside; Martin Pitt; Rob Anderson; Gabriel Rogers; M Dyer; Stuart Mealing; Margaret Somerville; A Price; Ken Stein
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Health technology assessment (Winchester, England) 2007;11(45):iii-iv, ix-221.
2007: Joanna Thompson-Coon; Gabriel Rogers; Paul Hewson; Dave Wright; Rob Anderson; Matthew Cramp; S Jackson; S Ryder; A Price; Ken Stein
Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.
Health technology assessment (Winchester, England) 2007;11(34):1-206.
2007: Julian Elston; Ken Stein
A rapid needs assessment of the provision of Health Technology Assessment in the south-west peninsula.
Journal of public health (Oxford, England) 2007;29(2):157-64.
2007: Ruth Garside; Martin Pitt; Rob Anderson; Stuart Mealing; C Roome; A Snaith; R D'Souza; K Welch; Ken Stein
The effectiveness and cost-effectiveness of cinacalcet for secondary hyperparathyroidism in end-stage renal disease patients on dialysis: a systematic review and economic evaluation.
Health technology assessment (Winchester, England) 2007;11(18):iii, xi-xiii, 1-167.
2007: Ruth Garside; Martin Pitt; Rob Anderson; Stuart Mealing; Richard D'Souza; Ken Stein
The cost-utility of cinacalcet in addition to standard care compared to standard care alone for secondary hyperparathyroidism in end-stage renal disease: a UK perspective.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(5):1428-36.
2007: Darren M Ashcroft; L-C Chen; Ruth Garside; Ken Stein; Hywel Williams
Topical pimecrolimus for eczema.
Cochrane database of systematic reviews (Online) 2007;(4):CD005500.
2007: Ken Stein; Catherine Sugar; Galina Velikova; Dan Stark
Putting the 'Q' in quality adjusted life years (QALYs) for advanced ovarian cancer - An approach using data clustering methods and the internet.
European journal of cancer (Oxford, England : 1990) 2007;43(1):104-13.
2006: Kim Dalziel; Ken Stein; Alison Round; Ruth Garside; Pamela Royle
Endoscopic sinus surgery for the excision of nasal polyps: A systematic review of safety and effectiveness.
American journal of rhinology 2006;20(5):506-19.
2006: Emanuela Castelnuovo; Joanna Thompson-Coon; Martin Pitt; Matthew Cramp; U Siebert; A Price; Ken Stein
The cost-effectiveness of testing for hepatitis C in former injecting drug users.
Health technology assessment (Winchester, England) 2006;10(32):iii-iv, ix-xii, 1-93.
2006: Joanna Thompson-Coon; Emanuela Castelnuovo; Martin Pitt; Matthew Cramp; Uwe Siebert; Ken Stein
Case finding for hepatitis C in primary care: a cost utility analysis.
Family practice 2006;23(4):393-406.
2006: Martin Pitt; Ruth Garside; Ken Stein
A cost-utility analysis of pimecrolimus vs. topical corticosteroids and emollients for the treatment of mild and moderate atopic eczema.
The British journal of dermatology 2006;154(6):1137-46.
2006: Ruth Garside; Martin Pitt; Margaret Somerville; Ken Stein; A Price; N Gilbert
Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.
Health technology assessment (Winchester, England) 2006;10(8):1-142, iii-iv.
2006: Ken Stein; Matthew Dyer; Tania Crabb; Ruairidh Milne; Alison Round; Julie Ratcliffe; John Brazier
A pilot Internet "value of health" panel: recruitment, participation and compliance.
Health and quality of life outcomes 2006;4():90.
2006: Matthew J Dyer; David M G Halpin; Ken Stein
Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review.
BMC family practice 2006;7():34.
2006: Ken Stein; Julie Ratcliffe; Alison Round; Ruairidh Milne; John E Brazier
Impact of discussion on preferences elicited in a group setting.
Health and quality of life outcomes 2006;4():22.
2005: Emanuela Castelnuovo; Ken Stein; Martin Pitt; Ruth Garside; E Payne
The effectiveness and cost-effectiveness of dual-chamber pacemakers compared with single-chamber pacemakers for bradycardia due to atrioventricular block or sick sinus syndrome: systematic review and economic evaluation.
Health technology assessment (Winchester, England) 2005;9(43):iii, xi-xiii, 1-246.
2005: Ruth Garside; Ken Stein; Emanuela Castelnuovo; Martin Pitt; Darren M Ashcroft; P Dimmock; L Payne
The effectiveness and cost-effectiveness of pimecrolimus and tacrolimus for atopic eczema: a systematic review and economic evaluation.
Health technology assessment (Winchester, England) 2005;9(29):iii, xi-xiii,1-230.
2005: Darren M Ashcroft; Paul Dimmock; Ruth Garside; Ken Stein; Hywel Williams
Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials.
BMJ (Clinical research ed.) 2005;330(7490):516.
2005: Ken Stein; Alison Fry; Alison Round; Ruairidh Milne; John Brazier
What value health?: A review of health state values used in early technology assessments for NICE.
Applied health economics and health policy 2005;4(4):219-28.
2005: Ken Stein; G Lewendon; R Jenkins; C Davis
Improving uptake of cervical cancer screening in women with prolonged history of non-attendance for screening: a randomized trial of enhanced invitation methods.
Journal of medical screening 2005;12(4):185-9.
2005: Ken Stein; Kim Dalziel; Ruth Garside; Emanuela Castelnuovo; Alison Round
Association between methodological characteristics and outcome in health technology assessments which included case series.
International journal of technology assessment in health care 2005;21(3):277-87.
2005: Kim Dalziel; Alison Round; Ruth Garside; Ken Stein
Cost effectiveness of imatinib compared with interferon-alpha or hydroxycarbamide for first-line treatment of chronic myeloid leukaemia.
PharmacoEconomics 2005;23(5):515-26.
2005: Ruth Garside; Ken Stein; Katrina Wyatt; Alison Round
Microwave and thermal balloon ablation for heavy menstrual bleeding: a systematic review.
BJOG : an international journal of obstetrics and gynaecology 2005;112(1):12-23.
2005: Kim Dalziel; Alison Round; Ken Stein; Ruth Garside; Emanuela Castelnuovo; L Payne
Do the findings of case series studies vary significantly according to methodological characteristics?
Health technology assessment (Winchester, England) 2005;9(2):iii-iv, 1-146.
2004: J A Horne; A J Clements; P Drennan; Ken Stein; M E Cramp
Screening for hepatitis C virus in the Dartmoor prison population: an observational study.
Journal of public health (Oxford, England) 2004;26(4):372-5.
2004: Ruth Garside; Ken Stein; Katrina Wyatt; Alison Round; Martin Pitt
A cost-utility analysis of microwave and thermal balloon endometrial ablation techniques for the treatment of heavy menstrual bleeding.
BJOG : an international journal of obstetrics and gynaecology 2004;111(10):1103-14.
2004: Kim Dalziel; Alison Round; Ken Stein; Ruth Garside; A Price
Effectiveness and cost-effectiveness of imatinib for first-line treatment of chronic myeloid leukaemia in chronic phase: a systematic review and economic analysis.
Health technology assessment (Winchester, England) 2004;8(28):iii, 1-120.
2004: Sandy Oliver; L Clarke-Jones; Rebecca Rees; Ruairidh Milne; P Buchanan; John Gabbay; G Gyte; Ann Oakley; Ken Stein
Involving consumers in research and development agenda setting for the NHS: developing an evidence-based approach.
Health technology assessment (Winchester, England) 2004;8(15):1-148, III-IV.
2004: Ken Stein; Kim Dalziel; Andrew Walker; Becky Jenkins; Alison Round; Pamela Royle
Screening for Hepatitis C in injecting drug users: a cost utility analysis.
Journal of public health (Oxford, England) 2004;26(1):61-71.
2004: Ruth Garside; Ken Stein; Katrina Wyatt; Alison Round; A Price
The effectiveness and cost-effectiveness of microwave and thermal balloon endometrial ablation for heavy menstrual bleeding: a systematic review and economic modelling.
Health technology assessment (Winchester, England) 2004;8(3):iii, 1-155.
2003: Ken Stein; Kim Dalziel; Andrew Walker; Becky Jenkins; Alison Round; Pamela Royle
Screening for hepatitis C in genito-urinary medicine clinics: a cost utility analysis.
Journal of hepatology 2003;39(5):814-25.
2003: Kim Dalziel; Ken Stein; Alison Round; Ruth Garside; Pamela Royle
Systematic review of endoscopic sinus surgery for nasal polyps.
Health technology assessment (Winchester, England) 2003;7(17):iii, 1-159.
2002: Ken Stein; Becky Jenkins; Harvey Gamble; Khaled Aziz
Predictive value of asthma medication to identify asthma sufferers.
The British journal of general practice : the journal of the Royal College of General Practitioners 2002;52(475):154; author reply 154-5.
2002: Ken Stein; W Rosenberg; J Wong
Cost effectiveness of combination therapy for hepatitis C: a decision analytic model.
Gut 2002;50(2):253-8.
2002: Ruth Garside; Alison Round; Kim Dalziel; Ken Stein; Pamela Royle
The effectiveness and cost-effectiveness of imatinib in chronic myeloid leukaemia: a systematic review.
Health technology assessment (Winchester, England) 2002;6(33):1-162.
2002: Ken Stein; Kim Dalziel; Andrew Walker; L McIntyre; Becky Jenkins; J Horne; Pamela Royle; Alison Round
Screening for hepatitis C among injecting drug users and in genitourinary medicine clinics: systematic reviews of effectiveness, modelling study and national survey of current practice.
Health technology assessment (Winchester, England) 2002;6(31):1-122.
2000: Jonathan Shepherd; Ken Stein; Ruairidh Milne
Eye movement desensitization and reprocessing in the treatment of post-traumatic stress disorder: a review of an emerging therapy.
Psychological medicine 2000;30(4):863-71.
2000: D Chase; Ruairidh Milne; Ken Stein; Andrew J Stevens
What are the relative merits of the sources used to identify potential research priorities for the NHS HTA programme?
International journal of technology assessment in health care 2000;16(3):743-50.
2000: A Smithies; T Nicholson; Ken Stein
Health technology assessment in primary and community care.
The British journal of general practice : the journal of the Royal College of General Practitioners 2000;50(450):3-4.
1999: F Christopher; D Chase; Ken Stein; Ruairidh Milne
rhDNase therapy for the treatment of cystic fibrosis patients with mild to moderate lung disease.
Journal of clinical pharmacy and therapeutics 1999;24(6):415-26.
1999: Ken Stein
DEC methods for appraising new drugs. Are justified.
BMJ (Clinical research ed.) 1999;319(7215):1005-6; author reply 1006-7.
1999: Ken Stein; D Ball
Contact between people with learning disability and general practitioners: a cross-sectional case note survey.
Journal of public health medicine 1999;21(2):192-8.
1999: Ken Stein; N Allen
Cross sectional survey of cervical cancer screening in women with learning disability.
BMJ (Clinical research ed.) 1999;318(7184):641.
1999: P Leal; Ken Stein; W Rosenberg
What is the cost utility of screening for hepatitis C virus (HCV) in intravenous drug users?
Journal of medical screening 1999;6(3):124-31.
1998: Tom Walley; M Rawlins; Ken Stein
Health technology assessment--the role of the pharmaceutical panel.
British journal of clinical pharmacology 1998;45(3):217-20.
1997: Ken Stein; Ruairidh Milne; L Best
Advertisements for donepezil. BMJ should require advertisements to detail actual state of evidence.
BMJ (Clinical research ed.) 1997;315(7122):1623-4.
1997: D C Jones; D Anthony; L Best; Ruairidh Milne; Ken Stein
Rationing of growth hormone: who reviews the experts?
Lancet 1997;350(9089):1483-4; author reply 1484.
1997: A Clark; J Hook; Ken Stein
Counsellors in primary care in Southampton: a questionnaire survey of their qualifications, working arrangements, and casemix.
The British journal of general practice : the journal of the Royal College of General Practitioners 1997;47(423):613-7.
1996: A Herbert; Ken Stein; T N Bryant; C Breen; P Old
Relation between the incidence of invasive cervical cancer and the screening interval: is a five year interval too long?
Journal of medical screening 1996;3(3):140-5.
1994: Ken Stein; A Mortimore
Audit of management of induced abortion. Primary care component is ignored.
BMJ (Clinical research ed.) 1994;309(6954):609.